IL72545A - Liposomes comprising anti-microbial agents and their preparation - Google Patents

Liposomes comprising anti-microbial agents and their preparation

Info

Publication number
IL72545A
IL72545A IL72545A IL7254584A IL72545A IL 72545 A IL72545 A IL 72545A IL 72545 A IL72545 A IL 72545A IL 7254584 A IL7254584 A IL 7254584A IL 72545 A IL72545 A IL 72545A
Authority
IL
Israel
Prior art keywords
liposomes
preparation
microbial agents
microbial
agents
Prior art date
Application number
IL72545A
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of IL72545A publication Critical patent/IL72545A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL72545A 1983-08-01 1984-07-30 Liposomes comprising anti-microbial agents and their preparation IL72545A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51891283A 1983-08-01 1983-08-01
US06/633,481 US5000958A (en) 1983-08-01 1984-07-26 Enhancement of pharmaceutical activity

Publications (1)

Publication Number Publication Date
IL72545A true IL72545A (en) 1987-11-30

Family

ID=27059635

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72545A IL72545A (en) 1983-08-01 1984-07-30 Liposomes comprising anti-microbial agents and their preparation

Country Status (11)

Country Link
US (1) US5000958A (fr)
EP (1) EP0153364B1 (fr)
AU (1) AU3219484A (fr)
CA (1) CA1237671A (fr)
DE (1) DE3483322D1 (fr)
ES (1) ES542147A0 (fr)
IL (1) IL72545A (fr)
IT (1) IT1179029B (fr)
PT (1) PT79012A (fr)
SG (1) SG18592G (fr)
WO (1) WO1985000515A1 (fr)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU588299B2 (en) * 1985-04-08 1989-09-14 Rafa Laboratories Ltd. Artificial microcompartmentalization
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
WO1987000043A1 (fr) * 1985-07-05 1987-01-15 The Liposome Company, Inc. Liposomes multilamellaires presentant une efficacite de capture amelioree
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
MX9203504A (es) * 1988-04-20 1992-07-01 Liposome Co Inc Complejo agente: lipido activo de alta proporcion.
EP0414806B1 (fr) * 1988-05-20 1994-07-20 The Liposome Company, Inc. Complexe agent actif:lipide a rapport eleve
CA1340241C (fr) * 1988-06-08 1998-12-15 Fountain Pharmaceuticals, Inc. Methode pour l'obtention de microvehicules, avec dilution dans un solvant
US5269979A (en) * 1988-06-08 1993-12-14 Fountain Pharmaceuticals, Inc. Method for making solvent dilution microcarriers
US4952405A (en) * 1988-10-20 1990-08-28 Liposome Technology, Inc. Method of treating M. avium infection
AU4525589A (en) * 1988-10-27 1990-05-14 Regents Of The University Of Minnesota Liposome immunoadjuvants containing il-2
DE69032161T2 (de) * 1989-05-25 1998-11-19 Technology Unlimited Inc Abstossmittel für insekten
ZA911974B (en) * 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
AU3423493A (en) * 1991-12-31 1993-07-28 Zymogenetics Inc. Methods and compositions for reducing blood loss
EP0585514B1 (fr) * 1992-01-09 1998-10-07 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d., Ljubljana Nourriture pour animaux, additif alimentaire ou eau potable contenant un mélange antibiotique de gentamicine avec lincomycine ou clindamycine
US5674855A (en) * 1992-08-12 1997-10-07 The Rogosin Institute Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
US5344822A (en) * 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
US5958449A (en) 1992-12-02 1999-09-28 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for bacterial infections
WO1994012155A1 (fr) * 1992-12-02 1994-06-09 Vestar, Inc. Formulation d'antibiotiques et son procede
US5759571A (en) * 1993-05-11 1998-06-02 Nexstar Pharmaceuticals, Inc. Antibiotic formulation and use for drug resistant infections
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
CA2172245C (fr) * 1993-09-22 2003-04-08 Jonathan Cohen Methode pour traiter l'infection bacterienne gram-negative par administration de proteines bactericides/augmentant la permeabilite (bpi)
EP0664117A1 (fr) * 1994-01-25 1995-07-26 F. Hoffmann-La Roche Ag Solutions de liposomes
US20020028215A1 (en) 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US6096336A (en) * 1996-01-30 2000-08-01 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
EE9800377A (et) 1996-05-08 1999-04-15 Biogen, Incorporated Ret-i ligand (RetL) närvi- ja neerukasvu stimuleerimiseks
WO1998006435A2 (fr) * 1996-08-14 1998-02-19 Vanderbilt University COMPOSITIONS D'AGENTS ANTI-CHLAMIDIAE POUR LE DIAGNOSTIC ET LE TRAITEMENT DES INFECTIONS BACTERIENNES A $i(CHLAMYDIAE)
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US6352996B1 (en) 1999-08-03 2002-03-05 The Stehlin Foundation For Cancer Research Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs
WO2003028646A2 (fr) * 2001-10-01 2003-04-10 The Board Of Trustees Of The University Of Illinois Methodes permettant de traiter des infections bacteriennes resistant aux medicaments
CA2383259A1 (fr) * 2002-04-23 2003-10-23 Celator Technologies Inc. Composes synergiques
US7850990B2 (en) * 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
EP1476194A4 (fr) * 2002-02-19 2005-05-18 Eden Research Plc Compositions et procedes de conservation d'aliments
WO2003075889A1 (fr) * 2002-03-05 2003-09-18 Transave, Inc. Systeme d'inhalation pour le traitement d'infections intracellulaires
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
DK2363114T3 (da) * 2002-10-29 2015-06-22 Insmed Inc Opretholdt afgivelse af anti-infektionsmidler
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US6846966B2 (en) * 2002-11-26 2005-01-25 Exxonmobil Chemical Patents Inc. Method and apparatus for treating oxygenate-containing feeds and their use in conversion of oxygenates to olefins
FR2852513A1 (fr) * 2003-03-17 2004-09-24 Groupe Lepine Combinaison d'antibiotiques gentamicine/clindamycine et ses applications aux ciments orthopediques curatifs
AU2004228631B2 (en) 2003-04-02 2010-12-02 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cholesterol-containing compounds and their use as immunogens against Borrelia burgdorferi
US20040204435A1 (en) * 2003-04-09 2004-10-14 Joachim Liehr Alternating treatment with topoisomerase I and topoisomerase II inhibitors
CA2561577A1 (fr) 2004-03-30 2005-10-13 Nsgene A/S Utilisation therapeutique d'un facteur de croissance, nsg33
US20090136552A1 (en) * 2004-07-30 2009-05-28 Mette Gronborg Growth factors nsg28, nsg30, and nsg32
WO2006032136A1 (fr) * 2004-09-20 2006-03-30 British Columbia Cancer Agency Branch Gemcitabine libre ou encapsulee dans des liposomes seule ou en association avec de l'idarubicine libre ou encapsulee dans des liposomes
US20110020434A1 (en) * 2005-09-02 2011-01-27 O'halloran Thomas V Nanoparticle arsenic-platinum compositions
DE102005063375A1 (de) * 2005-09-15 2007-04-19 Schülke & Mayr GmbH Antimikrobielle Zubereitungen mit einem Gehalt an Octenidindihydrochlorid verkapselt in Liposomen
CN101355876B (zh) 2005-11-09 2012-09-05 康宾纳特克斯公司 一种适用于眼部给药的组合物
PT1962805T (pt) 2005-12-08 2016-10-05 Insmed Inc Composições de anti-infeciosos baseadas em lípidos para tratamento de infeções pulmonares
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US8470762B2 (en) 2007-05-31 2013-06-25 Colgate-Palmolive Company Fabric softening compositions comprising polymeric materials
WO2009108407A1 (fr) * 2008-02-25 2009-09-03 The University Of North Carolina At Charlotte Office Of Technology Transfer Nanoparticules thérapeutiques biodégradables contenant un agent antimicrobien
US8039450B2 (en) 2008-03-06 2011-10-18 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
US20120172429A1 (en) 2009-07-10 2012-07-05 Woolf Clifford J Permanently charged sodium and calcium channel blockers as anti- inflammatory agents
AU2010330747B2 (en) 2009-12-18 2016-08-11 Achelios Therapeutics, Inc. Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions
WO2011094450A1 (fr) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Petites molecules contenant du bore
JP2013532144A (ja) 2010-06-14 2013-08-15 ハー・ルンドベック・アクチエゼルスカベット ＳｏｒＬＡとＧＤＮＦファミリーリガンド受容体の間の相互作用の調節
ES2606781T3 (es) * 2010-07-23 2017-03-27 Acea Biotech, Inc. Macrólidos polienos antifúngicos y antiparasitarios
AU2011307488B2 (en) 2010-10-01 2015-08-20 Hoba Therapeutics Aps Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
JP6402097B2 (ja) 2012-05-21 2018-10-10 インスメッド インコーポレイテッド 肺感染症を処置するためのシステム
MX2015006681A (es) 2012-11-29 2016-04-06 Insmed Inc Formulaciones de vancomicina estabilizadas.
WO2015175939A1 (fr) 2014-05-15 2015-11-19 Insmed Incorporated Méthodes de traitement d'infections pulmonaires mycobactériennes non-tuberculeuses
WO2015188140A1 (fr) * 2014-06-06 2015-12-10 The Curators Of The University Of Missouri Amélioration de l'efficacité antibiotique
EP3226972A4 (fr) 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Méthodes et compositions pour le traitement de la migraine et d'états pathologiques associés à la douleur
RU2018107695A (ru) 2015-08-03 2019-09-05 Президент Энд Феллоуз Оф Гарвард Колледж Заряженные блокаторы ионных каналов и способы их применения
JP2019532027A (ja) 2016-08-17 2019-11-07 ソルスティス バイオロジクス，リミティッド ポリヌクレオチド構築物
WO2019006455A1 (fr) 2017-06-30 2019-01-03 Solstice Biologics, Ltd. Auxiliaires de phosphoramidites chiraux et leurs procédés d'utilisation
EP3773505A4 (fr) 2018-03-30 2021-12-22 Insmed Incorporated Procédés pour la fabrication continue de produits médicamenteux liposomaux
KR20210145164A (ko) 2019-03-11 2021-12-01 녹시온 테라퓨틱스 인코포레이티드 에스테르 치환된 이온 채널 차단제 및 사용 방법
AU2020237474A1 (en) 2019-03-11 2021-09-30 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
SG11202109720WA (en) 2019-03-11 2021-10-28 Nocion Therapeutics Inc Charged ion channel blockers and methods for use
US10828287B2 (en) 2019-03-11 2020-11-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
WO2021091586A1 (fr) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Bloqueurs de canaux ioniques chargés et leurs procédés d'utilisation
US10842798B1 (en) 2019-11-06 2020-11-24 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
AU2021236130A1 (en) 2020-03-11 2022-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CN117940149A (zh) 2021-05-06 2024-04-26 霍巴治疗公司 化疗诱导的神经性疼痛的预防和治疗
WO2023104960A1 (fr) 2021-12-10 2023-06-15 Hoba Therapeutics Aps Traitement de la douleur nociceptive

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231981A (en) * 1975-08-18 1977-03-10 Takeda Chem Ind Ltd Microcapsule preparation method
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4328222A (en) * 1978-11-21 1982-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions for parenteral or local administration
US4241046A (en) * 1978-11-30 1980-12-23 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase

Also Published As

Publication number Publication date
ES8603264A1 (es) 1985-12-16
CA1237671A (fr) 1988-06-07
SG18592G (en) 1992-04-16
IT1179029B (it) 1987-09-16
PT79012A (en) 1984-09-01
EP0153364A1 (fr) 1985-09-04
ES542147A0 (es) 1985-12-16
WO1985000515A1 (fr) 1985-02-14
EP0153364B1 (fr) 1990-09-26
IT8467767A0 (it) 1984-08-01
US5000958A (en) 1991-03-19
DE3483322D1 (de) 1990-10-31
IT8467767A1 (it) 1986-02-01
EP0153364A4 (fr) 1987-03-03
AU3219484A (en) 1985-03-04

Similar Documents

Publication Publication Date Title
IL72545A (en) Liposomes comprising anti-microbial agents and their preparation
GB2099301B (en) Antimicrobial carpet and preparation thereof
GB8304165D0 (en) Preparing liposomes and products
GB2145422B (en) Novel poly-esters their preparation and pharmacolgical use thereof
IL68250A (en) Plurilamellar vesicles and their preparation
PH19602A (en) Phenyl aliphatic-isoxazoloes useful as antiviral agents and preparation thereof
IL73041A0 (en) 1,3-diaryl-5-methylene-perhydropyrimidin-2-ones,their preparation and their use as herbicides
GB2138292B (en) Haloalkynes and their use as fungicides
CY1522A (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols preparation and uses
IL71658A (en) 17-sulfonylmethylene-steroids and their preparation
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
ZA842202B (en) Phenylaminobenzenealkanols and preparation
IL73876A (en) 7-acylamino-mitosanes and their preparation
GB2138293B (en) Novel pesticidal compositions and their use
EP0298706A3 (en) Glycans and their use as anti-viral agents
GB2117757B (en) Alkylspectinomycins and their preparation
GB2146329B (en) Naphthalenylimidazopyridine and derivatives and their preparation
DE3366497D1 (en) Antibacterial agents, their preparation and use
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
DE3477007D1 (en) Heat-sensitizing agents, their preparation and use
GR80455B (en) 3-azidocephalosporins as intremediates and novel antibacterial agents
GB2129001B (en) Epoxycarbacyclin derivatives their preparation and use
GB8410462D0 (en) Skin preparation composition
GB8323796D0 (en) Preparation of haloacetals and halodioxolanes
GB2141121B (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols and preparation